Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Nordic Nanovector ASA ( (DE:8NN) ) is now available.
Thor Medical ASA has completed a subsequent offering, raising NOK 10 million through the issuance of 4,000,000 new shares. This capital increase has been registered with the Norwegian Register of Business Enterprises, bringing the company’s total share capital to NOK 70,597,184, divided into 352,985,920 shares. This move is expected to strengthen Thor Medical’s financial position and support its operations in the radiopharmaceutical industry.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier of radionuclides, focusing primarily on alpha particle emitters derived from naturally occurring thorium. The company utilizes a proprietary production process that does not require irradiation or nuclear reactors, offering a reliable, environmentally friendly, and cost-efficient supply for the radiopharmaceutical industry. Thor Medical is based in Oslo, Norway, and is listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
Average Trading Volume: 2,085,096
Current Market Cap: NOK860.3M
Find detailed analytics on 8NN stock on TipRanks’ Stock Analysis page.